{
  "doc_id": "Glycogen-Storage-Disease-Type-I",
  "doc_filename": "Glycogen-Storage-Disease-Type-I.pdf",
  "top_entities": [
    {
      "name": "glycogen storage disease",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "glycogen",
      "mention_count": 1,
      "entity_type": "drug"
    }
  ],
  "file_size_bytes": 1586,
  "file_size_human": "1.5 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:18",
  "doi": null,
  "doi_url": null,
  "document_type_code": "DLA",
  "document_type_name": "Disease Landscape Analysis",
  "document_type_group": "Disease Landscape Analysis",
  "classification_confidence": 0.85,
  "title": "Glycogen Storage Disease Type I: Epidemiology and Population Prevalence",
  "short_description": "Clinical document detailing the prevalence and demographic distribution of Glycogen Storage Disease Type I across different populations.",
  "long_description": "This clinical research document provides epidemiological data on Glycogen Storage Disease Type I (GSDI), a rare genetic metabolic disorder. The document presents key prevalence statistics, indicating that GSDI occurs in approximately 1 in 100,000 births in the general population, with a notably higher prevalence of 1 in 20,000 among Ashkenazi Jewish populations. The document emphasizes that this condition affects males and females equally across all population groups, providing important demographic insights for healthcare providers and researchers studying this rare genetic disorder.",
  "document_date": "2026-01-07T22:25:18",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T04:54:04.075972"
}